Globe Life Inc. reported a director-level share sale that was filed with regulators following a February 6, 2026 transaction. According to the filing, director Mark A. Blinn sold 1,750 shares of the company's common stock at a price of $147.91 per share. The sale produced a total transaction value of $258,842.
Following this disposition, the filing shows that Blinn retains direct ownership of 1,373 shares. In addition to those holdings, the filing indicates he indirectly controls 3,372 shares held through a trust.
Those disclosures arrive alongside the company's fourth-quarter financial report for 2025. Globe Life recorded earnings per share of $3.39 for the quarter, falling short of the consensus expectation of $3.44. Revenue for the period was reported at $1.52 billion, compared with forecasts of $1.53 billion, also a slight miss.
The company's quarterly results therefore showed small shortfalls in both per-share profitability and top-line sales relative to market estimates. Market reaction to the results was described as modest, with the stock showing limited movement in premarket trading. Following the announcement, there were no significant analyst upgrades or downgrades reported in conjunction with the earnings release.
This combination of a reported insider sale and a quarterly report that narrowly missed expectations provides investors with updated information on both insider activity and recent financial performance. The regulatory filing documents the specifics of the director's sale and current holdings, while the earnings release supplies the most recent operating and revenue figures.
Because the filing and the earnings disclosure present concrete figures without additional commentary on motives or strategic changes, observers are left with the numerical record of the transaction and the quarter's results. The filing and the earnings report together form the factual basis for assessing recent developments at the company.